Careside Analyzer Highlighted at Lab War College.
Business Editors & Health/Medical Writers
NEW ORLEANS--(BW HealthWire)--June 5, 2000
The benefits to physicians and hospitals of the new Careside(TM) point-of-care (POC (Proof Of Concept) See PoC exploit.
POC - Point Of Contact ) blood testing system were highlighted at the recent Executive War College on Laboratory and Pathology Management.
"Careside's point-of-care testing point-of-care testing Lab medicine The analysis of clinical specimens as close as possible to the Pt, including bedside, ward–unit, or 'stat' regional response labs that service specified areas–eg, the ER or ICU system makes it feasible and economically competitive to run routine chemistry and hematology tests outside the core lab at the point of care," said Robert L. Michel, director of the Executive War College and editor-in-chief of The Dark Report, who featured Careside's technology at several War College sessions.
The Careside Analyzer, manufactured by Careside Inc. (AMEX AMEX
See: American Stock Exchange :CSA (1) (Canadian Standards Association, Toronto, Ontario, www.csa.ca) A standards-defining organization founded in 1919. It is involved in many industries, including electronics, communications and information technology. ;CSA.W), is the first single POC instrument to offer a broad test menu, encompassing 38 FDA-cleared or exempt tests in the categories of chemistry, electrochemistry electrochemistry, science dealing with the relationship between electricity and chemical changes. Of principal interest are the reactions that take place between electrodes and the electrolytes in electric and electrolytic cells (see electrolysis), as well as the and coagulation coagulation (kōăg'ylā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or . (Immunoassays will soon be added.) These tests represent the majority of all routine blood tests now ordered.
The system allows hospitals -- and doctors who have physician office laboratories -- to provide their patients quick test results without having to send patients or their blood samples elsewhere and wait longer for results.
"This technology meets all of the challenges required of point-of-care devices," said Tom Grove, Ph.D., Careside's executive VP and chief technology officer. "It has taken the complex, multi-step procedure of doing routine blood tests and reduced it to a simple, three-step procedure that is easy to use. You can get the test results you want, when you want them, at the point of care."
The compact, desktop Careside Analyzer performs up to eight tests at a time, while delivering results in just four to 12 minutes. Its small test cartridges utilize the same "gold standard" testing formats used on large, expensive analyzers in clinical laboratories: spectral transmittance, reflectance and electrochemical electrochemical /elec·tro·chem·i·cal/ (-kem´i-k'l) pertaining to interaction or interconversion of chemical and electrical energies.
adj. . Careside also offers the H-2000 hematology analyzer as a companion to the Careside Analyzer.
The competitively priced system features an easily understood touch screen and built-in quality control/quality assurance software that captures most of the data necessary for CLIA CLIA Clinical Laboratory Improvement Amendments of 1988 Congressional legislation that promulgated quality assurance practices in clinical labs, and required them to measure performance at each step of the testing process from the beginning to the end-point of a compliance.
Careside will soon launch Careside Connect(TM), a universal data management system that interfaces the Careside Analyzer and H-2000 with any existing laboratory or hospital information system. The powerful Careside Connect will also allow users to directly input data via a barcode reader.
Careside Inc. is the world's leading developers of advanced point-of-care blood testing technology. The company's POC chemistry and hematology instruments have received FDA FDA
Food and Drug Administration
n.pr See Food and Drug Administration.
n.pr the abbreviation for the Food and Drug Administration. market clearance.
Safe Harbor Safe Harbor
1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.
2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. : Statements in this press release regarding Careside Inc. that are not historical facts are forward-looking statements that involve risks and uncertainties. Such forward-looking statements include future additions to the analyzer's test menu and introduction of the data management system. Key factors that may affect these statements include technological hurdles and other challenges inherent in product research, development, manufacturing, marketing, and other factors discussed in the company's prospectus. The company undertakes no obligation to update forward-looking statements. Please see the risk factors listed from time to time in the company's prospectus and reports on file with the SEC.